Article
<i>HER2</i>Amplification in Gastroesophageal Adenocarcinoma
19 Mar 2012
Abstract excerpt
We assessed 103 resected gastroesophageal adenocarcinomas for HER2 amplification by fluorescence in situ hybridization (FISH) and 2 commercial immunohistochemical assays. Of 103, 30 (29%) were FISH-amplified. Both immunohistochemical assays had greater than 95% concordance with FISH. However, as a screening test for FISH amplification, the Ventana Medical Systems (Tucson, AZ) 4B5 antibody demonstrated superior...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
